Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
IL-1 inhibitor and the anemia medical treatment use of a TNF antagonist which were partially combined with recombination erythropoietin
Document Type and Number:
Japanese Patent JP6073409
Kind Code:
B2
Abstract:
The invention relates to methods of treating a blood disorder in a mammal with an interleukin-1 (IL-1) inhibitor. The invention also relates to methods of treating a blood disorder in a mammal with an IL-1 inhibitor, a TNF inhibitor and an erythropoietin (EPO) receptor agonist. The invention also relates to compositions of an IL-1 inhibitor and compositions of an IL-1 inhibitor, a TNF inhibitor and an EPO receptor agonist.

More Like This:
WO/2002/100425AGGREGATE COMPOSITION FOR SUSTAINED−RELEASE PREPARATION, PROCESS FOR PRODUCING THE SAME, AND SUSTAINED−RELEASE PREPARATION CONTAINING THE SAME
JPH06508344INDUSTRIAL APPLICABILITY: Apo AI polypeptide, antibody and immunoassay
JP2904918INDUSTRIAL APPLICABILITY [Title of invention] New thrombolytic agent
Inventors:
Jyonathan Kay
Dorothy Matsucave
Richard Newmark
Marco A. Kotuchiya
Application Number:
JP2015099735A
Publication Date:
February 01, 2017
Filing Date:
May 15, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Amjien Incorporated
International Classes:
A61K38/00; A61K47/02; A61K38/18; A61K38/20; A61K39/395; A61K45/00; A61K45/06; A61K47/12; A61K47/48; A61P7/06; C07K14/52; C07K19/00
Domestic Patent References:
JP10304888A
Foreign References:
US5998598
WO2000024893A1
Other References:
CARLIN, B., et al.,Arthritis & Rheumatism,37(9 suppl.),p.S249 (1994)
別冊・医学のあゆみ 血液疾患-state of arts,1993年,p243-245
堀田 知光,日常診療と血液,2(3),pp.281-285 (1992)
MACDOUGALL, I.C., et al.,JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,10,pp.2392-2395 (1999)
Attorney, Agent or Firm:
Katsuma Osaki



 
Previous Patent: A high-speed adjustment liquid pressure supply device for a robot device

Next Patent: SNAP GAGE FOR INSPECTING SIZE OF WORKPIECE